NCT03833908View on ClinicalTrials.gov

Evaluation of the Performance of MAF-1217 on Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 20, 2018

Primary Completion Date

June 17, 2019

Study Completion Date

June 17, 2019

Conditions
Dry Eye
Interventions
DEVICE

MAF-1217

Patients will be enrolled at screening (2 weeks before surgery), then will be randomized with a 1:1 ratio to 2 groups of 23 patients each: A. patients receiving MAF-1217 B. patients receiving just standard antibiotic therapy

Trial Locations (2)

20121

Ospedale San Paolo, ASST Santi Paolo e Carlo, Milan

50134

Università di Firenze, Clinica Oculistica II,, Florence

All Listed Sponsors
lead

VISUfarma SpA

INDUSTRY

NCT03833908 - Evaluation of the Performance of MAF-1217 on Cataract Surgery | Biotech Hunter | Biotech Hunter